On World #HeadAndNeckCancerDay, we reaffirm our commitment to supporting people living with head and neck cancer (HNC) and their caregivers — reminding them they’re #MadeofMore than their disease. Trish’s cancer diagnosis changed everything about her daily life — including how she approached mealtime. As treatment made eating more difficult, she and her husband found a new way to make sure Trish was getting the nutrients she needed: a simple smoothie. What started as a necessity, soon became a creative family ritual filled with quality time. Explore their full story and discover more recipes that may help make mealtime a little bit more approachable: https://xmrrwallet.com/cmx.pbit.ly/4kTQFX7
Eisai US
Pharmaceutical Manufacturing
Nutley, NJ 135,539 followers
Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://xmrrwallet.com/cmx.pbit.ly/3dkY
About us
At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US. Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.
- Website
-
http://xmrrwallet.com/cmx.pus.eisai.com
External link for Eisai US
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Nutley, NJ
- Type
- Public Company
- Founded
- 1995
- Specialties
- Neurology, Gastroenterology, Alzheimer's disease, Oncology, Epilepsy, Insomnia, Metastatic breast cancer, renal cell carcinoma, hepatocellular carcinoma, dementia, and endometrial cancer
Locations
-
Primary
200 Metro Blvd.
Nutley, NJ 07110, US
-
Employees at Eisai US
Updates
-
Our team has touched down in Toronto for the Alzheimer's Association® International Conference! Want to know where we’ll be? Those attending can find a full schedule of activities below, including presentations of new research. #AlzheimersDisease #AAIC2025
-
Our team is looking forward to meeting attendees at next week’s Alzheimer's Association® International Conference! We’ll be sharing our latest research on Alzheimer’s disease. See the full schedule of events on the AAIC website: https://xmrrwallet.com/cmx.pbit.ly/44Yh00d #AAIC2025 #AlzheimersDisease
-
-
#ICYMI, we presented 3-year follow-up data at #KCRS25. Renal cell carcinoma (#RCC) is the most common type of #kidneycancer and we’re proud to have shared research in this oral presentation to help patients facing this challenging disease. At Eisai, we remain deeply committed to advancing innovative cancer research and are grateful to the patients and researchers who help us contribute to the ongoing dialogue. https://xmrrwallet.com/cmx.pbit.ly/4lWQxa7 #Oncology
Learn About What We Shared at KCRS 2025
-
ICYMI: Eisai thought leaders, Drs. Lynn Kramer, Shobha Dhadda, and Janna Hutz came together last week alongside STAT Brand Studio for a dynamic discussion on the future of neurology and oncology drug discovery. Together, they explored innovative approaches to challenging diseases, discussed the power of collaboration and reflected on our ongoing commitment to patients. Register to view the full webinar recording on STAT here: https://xmrrwallet.com/cmx.plnkd.in/g-jgPJpi
-
At its core, our human health care mission is about listening. It means showing up–not just with answers, but with empathy. Alexis Washburn, Senior Associate, Government Affairs & Policy, shares the powerful role that listening plays in improving the lives of patients. #LifeAtEisai
-
At Eisai, our commitment to patients with #kidneycancer is at the heart of our renal cell carcinoma (RCC) research and treatments. We’re thrilled to join clinicians, researchers and advocates in Boston at #KCRS25 to help advance the field. Don’t miss our oral presentation featuring 3-year follow-up data in advanced non-clear cell #RCC at 1pm ET Friday to learn more: https://xmrrwallet.com/cmx.pbit.ly/4lWQxa7
Oral Presentation in Advanced Renal Cell Carcinoma
-
CancerCare’s Healing Hearts Bereavement Camp provides a safe space for those who have lost a loved one to cancer. We were honored to sponsor this event and help provide a supportive environment where families can come together and heal through therapeutic activities. Thank you CancerCare for providing such a helpful and much-needed resource to the cancer community!
-
-
Our researchers Corina Dutcus, MD, Janna Hutz, Jin Zhou, and Michael Nagle recently joined the Government Affairs team for a series of discussions with elected officials and their staffs in Washington, D.C. These meetings, which were part of PhRMA's annual Researcher Fly-In, provided an opportunity to highlight to policymakers our commitment to human health care and the importance of continued funding of critical federal research to maintain America’s leadership in biomedical innovation.
-
-
Supporting the emotional and practical needs of people impacted by cancer is a critical part of oncology care. Attending the 2025 AOSW Annual Conference, “Unite to Ignite: Cultivating Connections,” served as a reminder to lead with intention when caring for patients, families and care partners. We’re grateful for the oncology social workers whose dedication makes a meaningful difference to help improve cancer care. #LifeAtEisai
-